Rump L C, Wilde K, Bohmann C, Schollmeyer P
Medizinische Universitätsklinik Freiburg, Innere Medizin IV, Federal Republic of Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1992 Mar;345(3):300-8. doi: 10.1007/BF00168691.
The effects of the classical dopamine DA2-receptor agonist quinpirole (LY 171555) and the recently characterized DA2-receptor agonist, carmoxirole (EMD 45609), on neurotransmission in rat isolated kidney were investigated. After preincubation with 3H-noradrenaline, the renal nerves were electrically stimulated. The stimulation induced (S-I) outflow of radioactivity was taken as an index of noradrenaline release. Quinpirole (0.3 mumol/l) inhibited S-I outflow of radioactivity and pressor-responses to renal nerve stimulation (RNS) at 1 Hz. Both effects of quinpirole were blocked by the DA2-receptor antagonist S(-)-sulpiride (10 mumol/l). The alpha 1, alpha 2-adrenoceptor antagonist phentolamine (1 mumol/l) did not block the inhibitory effect of quinpirole. Carmoxirole (0.003 and 0.03 mumol/l) did not alter and carmoxirole (0.3 mumol/l) even enhanced S-I outflow of radioactivity, however, pressor responses to RNS were markedly reduced by carmoxirole (0.003-0.3 mumol/l). Pressor responses to RNS were also markedly reduced by the alpha 1-adrenoceptor antagonist prazosin (0.1 mumol/l). Carmoxirole (0.3 mumol/l), prazosin (0.1 mumol/l) and phentolamine (1 mumol/l) totally abolished pressor responses to exogenous noradrenaline (0.05 mumol/l). In contrast, quinpirole (0.3 mumol/l) did not alter pressor responses to exogenous noradrenaline (0.05 mumol/l). Furthermore, carmoxirole (0.003-0.3 mumol/l) markedly reduced pressor responses induced by the alpha 1-adrenoceptor agonist methoxamine (1 mumol/l) but even the highest concentration of carmoxirole (0.3 mumol/l) had no effect on pressor responses induced by bolus injections of either neuropeptide Y (1.5 ng) or angiotensin II (1 ng). Phentolamine (1 mumol/l) by itself markedly enhanced S-I outflow of radioactivity and pressor responses to RNS were virtually unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了经典多巴胺DA2受体激动剂喹吡罗(LY 171555)和最近鉴定的DA2受体激动剂卡莫西罗(EMD 45609)对大鼠离体肾脏神经传递的影响。用3H-去甲肾上腺素预孵育后,对肾神经进行电刺激。刺激诱导的(S-I)放射性流出被用作去甲肾上腺素释放的指标。喹吡罗(0.3μmol/L)在1Hz时抑制放射性的S-I流出和对肾神经刺激(RNS)的升压反应。喹吡罗的这两种作用均被DA2受体拮抗剂S(-)-舒必利(10μmol/L)阻断。α1、α2肾上腺素能受体拮抗剂酚妥拉明(1μmol/L)未阻断喹吡罗的抑制作用。卡莫西罗(0.003和0.03μmol/L)未改变,而卡莫西罗(0.3μmol/L)甚至增强了放射性的S-I流出,然而,卡莫西罗(0.003 - 0.3μmol/L)显著降低了对RNS的升压反应。α1肾上腺素能受体拮抗剂哌唑嗪(0.1μmol/L)也显著降低了对RNS的升压反应。卡莫西罗(0.3μmol/L)、哌唑嗪(0.1μmol/L)和酚妥拉明(1μmol/L)完全消除了对外源性去甲肾上腺素(0.05μmol/L)的升压反应。相比之下,喹吡罗(0.3μmol/L)未改变对外源性去甲肾上腺素(0.05μmol/L)的升压反应。此外,卡莫西罗(0.003 - 0.3μmol/L)显著降低了α1肾上腺素能受体激动剂甲氧明(1μmol/L)诱导的升压反应,但即使是最高浓度的卡莫西罗(0.3μmol/L)对大剂量注射神经肽Y(1.5ng)或血管紧张素II(1ng)诱导的升压反应也无影响。酚妥拉明(1μmol/L)本身显著增强了放射性的S-I流出,对RNS的升压反应实际上未改变。(摘要截断于250字)